4:33 PM
 | 
Apr 11, 2013
 |  BC Extra  |  Company News

Sanofi, PATH scale up semisynthetic artemisinin production

Sanofi (Euronext:SAN; NYSE:SNY) and OneWorld Health, the not-for-profit drug development affiliate of the Program for Appropriate Technology in Health (PATH), launched a commercial-scale production line for semisynthetic artemisinin, the main ingredient of artemisinin-based...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >